94 related articles for article (PubMed ID: 7596153)
1. Clinical significance of tissue polypeptide antigen in serum of acute nonlymphocytic leukemia.
Sadamori N; Mine M; Kawachi T; Hayashibara T; Itoyama T; Sasagawa I; Nakamura H; Tomonaga M
Leuk Res; 1995 Jun; 19(6):407-9. PubMed ID: 7596153
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serum thymidine kinase in adult T-cell leukaemia and acute myeloid leukaemia.
Sadamori N; Ichiba M; Mine M; Hakariya S; Hayashibara T; Itoyama T; Nakamura H; Tomonaga M; Hayashi K
Br J Haematol; 1995 May; 90(1):100-5. PubMed ID: 7786770
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of cytogenetic analyses in patients with acute nonlymphocytic leukemia treated with the same intensive chemotherapy.
Tashiro S; Kyo T; Tanaka K; Oguma N; Hashimoto T; Dohy H; Kamada N
Cancer; 1992 Dec; 70(12):2809-15. PubMed ID: 1451059
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of tissue polypeptide antigen (TPA) in head and neck carcinomas.
Becciolini A; Porciani S; Lanini A; Tommasi M; Olmi P; Chiavacci A
Acta Oncol; 1993; 32(3):295-9. PubMed ID: 8323767
[TBL] [Abstract][Full Text] [Related]
5. Monitoring lung cancer with tissue polypeptide antigen: an ancillary, profitable serum test to evaluate treatment response and posttreatment disease status.
Buccheri G; Ferrigno D
Lung Cancer; 1995 Oct; 13(2):155-68. PubMed ID: 8581395
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer.
Gaarenstroom KN; Bonfrer JM; Kenter GG; Korse CM; Hart AA; Trimbos JB; Helmerhorst TJ
Cancer; 1995 Sep; 76(5):807-13. PubMed ID: 8625184
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of tissue polypeptide antigen serum levels for monitoring disease activity during chemotherapy in patients with transitional carcinoma of the urinary tract.
van der Gaast A; Kirkels WJ; Blijenberg BG; Splinter TA
J Cancer Res Clin Oncol; 1992; 118(8):626-8. PubMed ID: 1517284
[TBL] [Abstract][Full Text] [Related]
8. Pre-operative serum levels of tissue polypeptide antigen in patients with gastric cancer.
Hsieh MC; Wu CW; Tsay SH; Lui WY; P'eng FK
J Gastroenterol Hepatol; 1995; 10(1):60-5. PubMed ID: 7620109
[TBL] [Abstract][Full Text] [Related]
9. Tissue polypeptide antigen for monitoring of advanced bladder cancer after MVEC chemotherapy.
Schmidt A; Bub P; Rüther U; Eisenberger F
Eur Urol; 1992; 21 Suppl 1():10-2. PubMed ID: 1425831
[TBL] [Abstract][Full Text] [Related]
10. The tissue polypeptide antigen serum test in the preoperative evaluation of non-small cell lung cancer. Diagnostic yield and comparison with conventional staging methods.
Buccheri G; Ferrigno D
Chest; 1995 Feb; 107(2):471-6. PubMed ID: 7842779
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment prognostic factors for overall survival in primary resistant acute myeloid leukemia.
Colovic N; Tomin D; Vidovic A; Suvajdzic N; Jankovic G; Palibrk V; Djunic I; Djurasinovic V; Virijevic M
Biomed Pharmacother; 2012 Dec; 66(8):578-82. PubMed ID: 23085253
[TBL] [Abstract][Full Text] [Related]
12. Clinical equivalence of two cytokeratin markers in mon-small cell lung cancer: a study of tissue polypeptide antigen and cytokeratin 19 fragments.
Buccheri G; Torchio P; Ferrigno D
Chest; 2003 Aug; 124(2):622-32. PubMed ID: 12907552
[TBL] [Abstract][Full Text] [Related]
13. [Treatment results in childhood acute myeloblastic leukemia--a report of clinical trials of a past decade from the Japanese children's Cancer and Leukemia Study Group (CCLSG)].
Tsurusawa M; Katano N; Hirota T; Mimaya J; Horikoshi Y; Kawamura N; Yanai M; Kamitamari A; Tsuji Y; Fujimoto T
Rinsho Ketsueki; 1997 Jun; 38(6):505-12. PubMed ID: 9248326
[TBL] [Abstract][Full Text] [Related]
14. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia.
Kalwinsky DK; Raimondi SC; Schell MJ; Mirro J; Santana VM; Behm F; Dahl GV; Williams D
J Clin Oncol; 1990 Jan; 8(1):75-83. PubMed ID: 2295913
[TBL] [Abstract][Full Text] [Related]
15. High-dose cytosine arabinoside and L-asparaginase therapy for poor-risk adult acute nonlymphocytic leukemia. A retrospective study.
Evans C; Winkelstein A; Rosenfeld CS; Zeigler ZR; Shadduck RK
Cancer; 1990 Jun; 65(12):2624-30. PubMed ID: 2340464
[TBL] [Abstract][Full Text] [Related]
16. Serum tissue polypeptide antigen (S-TPA) in bladder cancer as a tumor marker. A prospective study.
Maulard C; Toubert ME; Chretien Y; Delanian S; Dufour B; Housset M
Cancer; 1994 Jan; 73(2):394-8. PubMed ID: 8293406
[TBL] [Abstract][Full Text] [Related]
17. Clinical and morphological features of cases of trisomy 13 in acute non-lymphocytic leukemia.
Soni M; Brody J; Allen SL; Schulman P; Kolitz J; Rai K; Broome JD; Koduru PR
Leukemia; 1996 Apr; 10(4):619-23. PubMed ID: 8618437
[TBL] [Abstract][Full Text] [Related]
18. CD7 expression in acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Cox C; Aronica G; Masi M; Bruno A; Simone MD; Buccisano F; Papa G
Leuk Lymphoma; 1995 Mar; 17(1-2):111-9. PubMed ID: 7539657
[TBL] [Abstract][Full Text] [Related]
19. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
20. [The clinical and biological significance of P-glycoprotein expression in acute nonlymphocytic leukemia].
Li J; Xia X; Hua D
Zhonghua Nei Ke Za Zhi; 1997 May; 36(5):304-7. PubMed ID: 10374270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
